By using the dual screening approach, drug developers can identify new targets ... and the race to the market needs a rapid turnaround of data. Capacity can be a challenge, even for companies ...
Extensively drug-resistant (XDR-TB ... statement in 2008 for the use of molecular line-probe assays for the rapid screening of patients at risk of MDR-TB. This was extended to 27 countries ...